Cincinnati Infant Neurodevelopment Early Prediction Study (CINEPS)

Early Prediction of Cognitive and Motor Deficits Using Advanced MRI in Very Preterm Infants

The Early Prediction Study is a longitudinal population-based cohort study for very preterm infants ≤32 weeks gestational age. Preterm infants recruited from three greater Cincinnati and two Dayton area neonatal intensive care units (NICUs) will undergo advanced MRIs at 41 weeks postmenstrual age and neurodevelopmental testing at the corrected ages of two and three years correct age. The goal of the Early Prediction Study is to accurately predict motor, cognitive, and behavioral deficits in individual very preterm infants using neuroimaging technologies and established epidemiologic approaches.

Study Overview

Status

Active, not recruiting

Conditions

Detailed Description

With every neonatal intensive care unit discharge, physicians and early intervention specialists face a critical challenge: How to counsel parents about their very preterm infant's risk of developing cognitive and motor deficits and accurately assign early intervention therapies. More than 100,000 babies are born very preterm at ≤32 weeks gestational age every year in the United States. Up to 35% of these preterm survivors develop cognitive deficits, and up to 20% develop motor impairment. This places them at high risk for poor educational, health, and social outcomes. Yet reliable diagnosis of cognitive and motor deficits cannot be made until early childhood. This long and unnecessary delay wastes early intervention resources, dilutes the effectiveness of infant stimulation programs, and disrupts parental adaptation. Attempts to address these gaps with conventional neuroimaging and other approaches have failed. Thus, a critical need exists before neonatal discharge, to accurately predict cognitive and motor deficits in individual very preterm infants with the use of novel neuroimaging technologies and established epidemiologic approaches.

The investigators long-term research goal is to elucidate the etiology, pathogenesis, and early prediction of cognitive and motor deficits in order to facilitate preventive early interventions in very preterm infants, resulting in better outcomes. The investigators objectives in this application therefore are to:

  1. Identify the clinical antecedents of objectively diagnosed diffuse white matter abnormality (DWMA).
  2. Associate DWMA with pathologic changes on neuroimaging.
  3. Predict cognitive and behavioral deficits at 3 years of age using objectively diagnosed DWMA in a geographic cohort of very preterm infants.
  4. To predict motor impairment, especially cerebral palsy at 24 months corrected age.

The investigators central hypothesis is that objectively quantified DWMA is pathologic, associated with inflammation-associated perinatal illnesses, and an independent predictor of cognitive deficits at 3 years corrected age in very preterm infants. The investigators rationale for this research is that new knowledge investigators expect to have generated will enhance parental counseling, facilitate accurate risk stratification for early intervention therapies, and guide biologically-based strategies for early prevention of DWMA and cognitive and motor deficits in very preterm infants.

Study Type

Observational

Enrollment (Actual)

393

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ohio
      • Cincinnati, Ohio, United States, 45229
        • Cincinnati Children's Hospital Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 3 years (Child)

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

All very preterm infants (≤32 weeks completed gestational age) from a geographically-based population cared for in level III/IV NICUs in Cincinnati/Dayton are eligible. Those with known chromosomal or congenital anomalies affecting the central nervous system or with cyanotic heart disease will be excluded.

Description

Inclusion Criteria:

  • Hospitalized infants born at ≤32 weeks completed gestational age that are being cared for in all three level III/IV NICUs from the Greater Cincinnati area.

Exclusion Criteria:

  • Infants with known chromosomal or congenital anomalies affecting the central nervous system or with cyanotic heart disease.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Infants born very preterm
This is a single group prospective longitudinal, multisite cohort study of very preterm infants born at or below 32 weeks gestational age at birth

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Motor development
Time Frame: 2 years of age, corrected for prematurity
Standardized assessment and diagnosis of cerebral palsy at 2 years corrected age
2 years of age, corrected for prematurity
Cognitive development
Time Frame: 3 years of age, corrected for prematurity
General Conceptual Ability (GCA) score from the Differential Abilities Scale, 2nd Edition
3 years of age, corrected for prematurity
Behavioral development
Time Frame: 3 years of age, corrected for prematurity
Scores on the Child Behavior Checklist & Early Childhood Behavior Questionnaire - Short Form
3 years of age, corrected for prematurity

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cognitive and language deficits at 2years of age
Time Frame: 2 years of age, corrected for prematurity
Cognitive and language scores on Bayley Scales of Infant and Toddler Development, 3rd Ed
2 years of age, corrected for prematurity
Executive function
Time Frame: 3 years of age, corrected for prematurity
Computerized measures of executive function for preschoolers
3 years of age, corrected for prematurity
Behavioral development
Time Frame: 3 years of age, corrected for prematurity
General Adaptive Composite score on the Adaptive Behavior Assessment System, 2nd Ed.
3 years of age, corrected for prematurity
Pre-academic skills
Time Frame: 3 years of age, corrected for prematurity
Bracken School Readiness Assessment, 3rd Ed.
3 years of age, corrected for prematurity

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 16, 2016

Primary Completion (Estimated)

December 31, 2024

Study Completion (Estimated)

November 1, 2027

Study Registration Dates

First Submitted

November 8, 2017

First Submitted That Met QC Criteria

November 13, 2017

First Posted (Actual)

November 17, 2017

Study Record Updates

Last Update Posted (Actual)

February 7, 2024

Last Update Submitted That Met QC Criteria

February 5, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Premature Infant

Subscribe